Farestos

ACTIVE HALF-LIFE 6-7 Days
CLASSIFICATION Selective Estrogen Receptor Modulator (SERM)
DOSAGE 10-40 mg/day
ACNE None
WATER RETENTION None
HBR Not present
HEPATOTOXICITY None
AROMATIZATION None
MANUFACTURER Pharmacom Labs - US
LAB TEST Refer to Document
WAREHOUSE USA Warehouse 4
SUBSTANCE Toremifene Citrate

Introducing Farestos: the innovative and powerful alternative to Clomid, designed to encapsulate all its advantages!

Toremifene Citrate is a cutting-edge selective estrogen receptor modulator (SERM) derived from triphenylethylene. First patented in the mid-1990s, it received European approval for treating metastatic ER+ breast cancer in postmenopausal women.

In the world of bodybuilding, Toremifene Citrate is utilized as a post-cycle therapy (PCT) agent to alleviate and inhibit the negative effects of elevated estradiol resulting from the aromatization of various anabolic steroids. Specifically, this remarkable compound aids in restoring natural testosterone levels in the bloodstream while effectively preventing estrogen-related side effects, such as gynecomastia.

It?s crucial to understand that Toremifene Citrate acts as a true estrogen blocker, distinguishing it from aromatase inhibitors. By binding more effectively to estradiol receptors in various tissues, Toremifene prevents estradiol from attaching and activating those receptors, ensuring that its adverse effects are mitigated. Unlike aromatase inhibitors, which lower overall estradiol levels in the bloodstream, Toremifene regulates estradiol's action in targeted tissues without reducing its circulating levels.

Chemically similar to tamoxifen, Toremifene is a newer generation SERM with fewer toxic side effects. However, it does come with some considerations. Clinical studies show that while Toremifene stimulates natural testosterone production, it can also increase SHBG (Sex Hormone Binding Globulin) levels, potentially impacting cycle efficiency when used for gynecomastia management.

Regarding HPTA restoration and testosterone production in males, Toremifene is less effective than tamoxifen at equivalent doses. Research indicates that a daily dose of 60 mg of Toremifene resulted in a 42% increase in testosterone levels, while tamoxifen at 20 mg achieved a 71% increase in the same study.

For optimal testosterone enhancement, the recommended Toremifene dosage can be increased to 120 mg per day during the initial week of PCT, followed by 100 mg in the second week, and tapering to 60 mg per day for the final 3-4 weeks. Individual dosage should be adjusted based on personal blood work results.

No special requirements are needed for taking Toremifene. It can be consumed anytime?before, during, or after meals?and there?s no need to split the dosage throughout the day, thanks to its half-life of approximately 5 days, which allows for stable blood levels without the hassle of multiple daily doses.

The price listed is for a single blister containing 50 pills. If you order just one blister, it will be shipped without the original packaging. To receive the original box, please place an order for two blisters (100 pills).